Anaptysbio, Inc
ANAB
Revenue
108.25M
▲31.93M▲41.84%
3 Months ChangeAssets
364.40M
▲11.30M▲3.20%
3 Months ChangeLiabilities
327.19M
▼-55.33M▼-14.46%
3 Months ChangeFree Cash Flow
-10.74M
▲26.55M▲71.20%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001193125-26-088239
2026-01-09
Form 8-K
ID: 0001370053-26-000002
2025-11-26
Form 8-K
ID: 0001370053-25-000103
2025-11-21
Form 8-K
ID: 0001370053-25-000097
2025-11-21
Form 8-K
ID: 0001370053-25-000096
2025-11-10
Form 8-K
ID: 0001370053-25-000091
2025-11-04
Form 10-Q
ID: 0001370053-25-000089
2025-11-04
Form 8-K
ID: 0001370053-25-000088
2025-10-14
Form 8-K
ID: 0001370053-25-000083
2025-09-29
Form 8-K
ID: 0001370053-25-000081